| Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations D Brown, D Smeets, B Székely, D Larsimont, AM Szász, PY Adnet, ... Nature communications 8 (1), 14944, 2017 | 177 | 2017 |
| Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy B Ács, V Zámbó, L Vízkeleti, AM Szász, L Madaras, G Szentmártoni, ... Diagnostic pathology 12, 1-12, 2017 | 107 | 2017 |
| Review of the clinical evidences of modulated electro-hyperthermia (mEHT) method: an update for the practicing oncologist AM Szasz, CA Minnaar, G Szentmártoni, GP Szigeti, M Dank Frontiers in Oncology 9, 1012, 2019 | 51 | 2019 |
| Prognostic and clinicopathological correlations of cell cycle marker expressions before and after the primary systemic therapy of breast cancer T Tőkés, AM Tőkés, G Szentmártoni, G Kiszner, D Mühl, BÁ Molnár, ... Pathology & Oncology Research 26, 1499-1510, 2020 | 17 | 2020 |
| Immunohistochemical phenotype of breast carcinomas predicts the effectiveness of primary systemic therapy J Kulka, AM Tokés, AI Tóth, AM Szász, A Farkas, K Borka, B Járay, ... Magyar Onkológia 53 (4), 335-343, 2009 | 15 | 2009 |
| Comparison of immunophenotypes of primary breast carcinomas and multiple corresponding distant metastases: an autopsy study of 25 patients B Székely, ZI Nagy, Z Farago, O Kiss, G Lotz, KA Kovacs, L Madaras, ... Clinical & experimental metastasis 34, 103-113, 2017 | 14 | 2017 |
| Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer T Tőkés, AM Tőkés, G Szentmártoni, G Kiszner, L Madaras, J Kulka, ... Virchows Archiv 468, 675-686, 2016 | 12 | 2016 |
| Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer T Tőkés, K Kajáry, G Szentmártoni, Z Lengyel, T Györke, L Torgyík, ... Breast cancer 24, 137-146, 2017 | 11 | 2017 |
| Primary systemic therapy in breast cancer--an update for gynecologic oncologists. B Székely, G Szentmártoni, J Kulka, AM Szász, Z Langmár, M Dank Eur. J. Gynaec. Oncol.-ISSN 32 (6), 2011, 2011 | 9 | 2011 |
| Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study G Szentmártoni, AM Tőkés, T Tőkés, K Somlai, A Marcell Szász, L Torgyik, ... Croatian Medical Journal 57 (2), 131-139, 2016 | 8 | 2016 |
| Primary systemic therapy for breast cancer: Does the patient's involvement in decision-making create a new future? T Tőkés, L Torgyík, G Szentmártoni, K Somlai, A Tóth, J Kulka, M Dank Patient education and counseling 98 (6), 695-703, 2015 | 8 | 2015 |
| Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations. Nat Commun. 2017; 8: 14944 D Brown, D Smeets, B Székely, D Larsimont, AM Szász, PY Adnet, ... Nature Publishing Group, 0 | 8 | |
| Cerebral iodized lipid embolization via a pulmonary arteriovenous shunt: rare complication of transcatheter arterial embolization for hepatocellular carcinoma Z Bánsághi, PN Kaposi, G Lovas, G Szentmártoni, G Várallyay, P Bata, ... world journal of surgical oncology 11, 1-6, 2013 | 7 | 2013 |
| The role of FDG-PET-CT in the evaluation of primary systemic therapy in breast cancer: links between metabolic and pathological remission T Tőkés, K Somlai, B Székely, J Kulka, G Szentmártoni, L Torgyík, ... Orvosi hetilap 153 (49), 1958-1964, 2012 | 7 | 2012 |
| A fiatal-és időskori emlőrák összehasonlítása klinikopatológiai jellemzők alapján B Székely, L Madaras, G Szentmártoni, AM Szász, Z Baranyák, L Szittya, ... Magyar Onkológia 54 (1), 19-26, 2010 | 7 | 2010 |
| Chemobrain G Szentmartoni, Z Makkos, M Dank Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet …, 2018 | 6 | 2018 |
| Complexity of Response Evaluation During Primary Systemic Therapy of Breast Cancer: Scoring Systems and Beyond–Preliminary Results T Tőkés, G Szentmártoni, L Torgyik, K Somlai, J Kulka, Z Lengyel, ... Anticancer Research 35 (9), 5063-5072, 2015 | 6 | 2015 |
| Comparison of breast cancer in young and old women based on clinicopathological features B Székely, L Madaras, G Szentmártoni, AM Szász, Z Baranyák, L Szittya, ... Magyar Onkologia 54 (1), 19-26, 2010 | 6 | 2010 |
| Az emlődaganatok primer szisztémás kemoterápiára adott válasza az immunhisztokémiai fenotípus tükrében J Kulka, AM Tőkés, AI Tóth, AM Szász, A Farkas, K Borka, B Járay, ... Magyar Onkológia 53 (4), 335-343, 2009 | 6 | 2009 |
| Morphological and immunophenotypical heterogeneity in breast cancers of young and elderly women L Madaras, MA Szász, Z Baranyák, AM Tõkés, L Szittya, G Lotz, B Székely, ... Magyar Onkologia 56 (2), 75-78, 2012 | 5 | 2012 |
